ALW-II-41-27

Modify Date: 2024-01-09 13:40:05

ALW-II-41-27 Structure
ALW-II-41-27 structure
Common Name ALW-II-41-27
CAS Number 1186206-79-0 Molecular Weight 607.68900
Density N/A Boiling Point N/A
Molecular Formula C32H32F3N5O2S Melting Point N/A
MSDS N/A Flash Point N/A

 Use of ALW-II-41-27


ALW-II-41-27 is a Eph family tyrosine kinase inhibitor with an IC50 of 11 nM for Eph2.

 Names

Name N-[5-[[4-[(4-ethylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]carbamoyl]-2-methylphenyl]-5-thiophen-2-ylpyridine-3-carboxamide
Synonym More Synonyms

 ALW-II-41-27 Biological Activity

Description ALW-II-41-27 is a Eph family tyrosine kinase inhibitor with an IC50 of 11 nM for Eph2.
Related Catalog
Target

IC50: 11 nM (Eph2)[1]

In Vitro ALW-II-41-27 inhibits Ba/F3 cells transformed with Tel fusions of EphA3, Kit, Fms, KDR, FLT1, FGR, Src, Lyn, Bmx, and Bcr-Abl with an EC50 below 500 nM. ALW-II-41-27 exhibits cross reactivity with Bcr-Abl. ALW-II-41-27 inhibits b-raf, CSF1R, DDR1, DDR2, EphA2, EphA5, EphA8, EphB1, EphB2, EphB3, Frk, Kit, Lck, p38α, p38β, PDGFRα, PDGFRβ, and Raf1 and many more demonstrating how introduction of the thiophene group can have a tremendous impact on kinase selectivity[1].
References

[1]. Choi, et al. Discovery and structural analysis of Eph receptor tyrosine kinase inhibitors. Bioorganic & Medicinal Chemistry Letters (2009), 19(15), 4467-4470.

[2]. Song W, et al. Targeting EphA2 impairs cell cycle progression and growth of basal-like/triple-negative breast cancers. Oncogene. 2017 Jun 5.

 Chemical & Physical Properties

Molecular Formula C32H32F3N5O2S
Molecular Weight 607.68900
Exact Mass 607.22300
PSA 112.79000
LogP 7.42320
Storage condition 2-8℃

 Precursor & DownStream

Precursor  2

DownStream  0

 Synonyms

hms2043h01
hms2218g07
cs-1203
alw-ii-41-27